A detailed history of Petrus Trust Company, Lta transactions in Rx Sight, Inc. stock. As of the latest transaction made, Petrus Trust Company, Lta holds 18,713 shares of RXST stock, worth $553,904. This represents 0.07% of its overall portfolio holdings.

Number of Shares
18,713
Previous 4,932 279.42%
Holding current value
$553,904
Previous $243,000 164.61%
% of portfolio
0.07%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$33.66 - $54.73 $463,868 - $754,234
13,781 Added 279.42%
18,713 $643,000
Q3 2024

Nov 14, 2024

SELL
$40.78 - $57.04 $14,150 - $19,792
-347 Reduced 6.57%
4,932 $243,000
Q2 2024

Aug 14, 2024

SELL
$50.42 - $64.29 $246,301 - $314,056
-4,885 Reduced 48.06%
5,279 $317,000
Q1 2024

May 15, 2024

SELL
$35.51 - $57.92 $145,519 - $237,356
-4,098 Reduced 28.73%
10,164 $524,000
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $298,218 - $583,315
14,262 New
14,262 $575,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $818M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.